WellDoc

WellDoc

WellDoc

WellDoc®, maker of the first FDA cleared Mobile Prescription Therapy, BlueStar® for Type 2 Diabetes. WellDoc engages patients and enhances health outcomes.
Raised
$7.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$7,500,000
Venture capital (Series B) - 2016
Johnson & Johnson Innovation
Team Size
1–10
Employees
$7,500,000 Venture capital (Series B)
FinSMEs

WellDoc Raises Additional $7.5M in Series B Funding

Health
$22,000,000 Venture capital (Series B)
GlobeNewswire News Room

WellDoc® Raises $22 Million in Series B Funding From Samsung Ventures, Merck Global Health Innovation Fund and Other Lea...